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Virus entryirus (IBDV), a member of the dsRNA Birnaviridae family, is an important
immunosuppressive avian pathogen. We have identiﬁed a strictly conserved amino acid triplet matching the
consensus sequence used by ﬁbronectin to bind the α4β1 integrin within the protruding domain of the IBDV
capsid polypeptide. We show that a single point mutation on this triplet abolishes the cell-binding activity of
IBDV-derived subviral particles (SVP), and abrogates the recovering of infectious IBDV by reverse genetics
without affecting the overall SVP architecture. Additionally, we demonstrate that the presence of the α4β1
heterodimer is a critical determinant for the susceptibility of murine BALB/c 3T3 cells to IBDV binding and
infectivity. Our data suggests that the IBDV might also use the α4β1 integrin as a speciﬁc binding receptor in
avian cells.
© 2008 Elsevier Inc. All rights reserved.IntroductionInfectious bursal disease virus (IBDV) is the best characterized
member of the Birnaviridae family that groups naked viruses with a
bipartite double-stranded (dsRNA) RNA genome (Delmas et al., 2004).
IBDV is responsible for an immunosuppressive disease that affects
young domestic chickens (Gallus gallus), and causes major economic
losses to the poultry industry world-wide (van den Berg et al., 2000).
The knowledge about IBDV structural and molecular biology has
experienced a great progress over the last few years, thus the crystal
structure of all structural polypeptides has been completely or
partially solved (Casañas et al., 2008; Coulibaly et al., 2005; Feldman
et al., 2006; Garriga et al., 2007, 2006; Lee et al., 2006; Pan et al.,
2007), and the virus assembly pathway has been extensively
characterized (Chevalier et al., 2005; Luque, 2007; Oña et al., 2004;
Saugar et al., 2005). However, our understanding about fundamental
aspects of the virus replication cycle, e.g. the entry and egress
mechanisms is, as yet, scarce.
Viruses are obligate intracellular parasites, thus the ﬁrst require-
ment to initiate a successful infection consists on the recognition of a
suitable receptor(s) on the surface of target cells. This recognition sets
off a series of events, generally involving an elaborated interplay
between different cellular and viral components, allowing the virus toMadrid, Spain.
ll rights reserved.reach the appropriate cellular compartment for virus replication
(Smith and Helenius, 2004). Indeed, the presence and distribution of
speciﬁc virus receptor(s) molecules are in many cases critical
determinants for virus host-range, tropism, and pathogenesis.
The IBDV capsid (65–70 nm in diameter) is a single shell built by
260 trimers of the VP2 polypeptide arranged in an icosahedral lattice
with T=13l symmetry (Bottcher et al., 1997; Coulibaly et al., 2005;
Saugar et al., 2005). VP2 is produced by proteolytic maturation of a
precursor polypeptide, known as pVP2 (Birghan et al., 2000; Feldman
et al., 2006). VP2 is the only component of the virus capsid, and thus
responsible to the interaction with host cell receptors. Although the
tropism of IBDV for lymphocytic cell populations found at the
Fabricius bursa has been extensively characterized (Becht, 1980;
Kibenge et al., 1988), the identiﬁcation of speciﬁc cell binding receptor
(s) has remained elusive.
The VP2 crystal structure, independently solved by three different
groups (Coulibaly et al., 2005; Garriga et al., 2006; Lee et al., 2006),
revealed the presence of three distinct domains designated base (B),
shell (S), and projection (P) (Fig. 1A). Domain P, formed by a β-barrel
with a jelly roll topology, is well exposed to the solvent, thus being a
likely candidate to interacting with the host cell binding receptor(s).
This hypothesis is supported by the presence within this domain of
several neutralizing epitopes (Fahey et al., 1989), and amino-acid
residues directly involved both in virulence and tissue-culture
adaptation (Brandt et al., 2001; van Loon et al., 2002). Additionally,
the P domain shows a high degree of structural homology with
projection domains of reovirus capsid polypeptides directly involved
Fig. 1. Identiﬁcation of a conserved putative integrin binding motif on the VP2 capsid
polypeptide. (A) Ribbon diagram of the VP2 polypeptide. The three VP2 domains,
namely P, S, and B, colored in red, blue, and green, respectively, are delimited by arrows.
The lateral chains of the IDA motif amino acid residues are shown in dark green. The
position of the C and D β-strands is indicated. (B) Multiple alignment comparing the
predicted amino acid sequences of the IBDV VP2 from attenuated (D78), classical
virulent (52/70), very virulent (UK661), and variant (Variant E) serotype 1, and
classical serotype 2 (OH) strains to that of the virulent serotype 1 Soroa isolate. The
image shows 20 residues-long protein regions containing the putative IDA integrin
binding motif (shown in bold). Non-strictly conserved residues are shown in red. The
amino acid positions and the GenBank accession numbers of the different proteins are
indicated on the right.
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2006; López and Arias, 2004; Maginnis et al., 2006; Tan et al., 2001).
Early studies on the nature of the IBDV cell receptor(s) showed
that the treatment of chicken B lymphoblastoid cells with proteases
and/or N-glycosylation inhibitors cause a major reduction on IBDV
infectivity, thus strongly suggesting the involvement of a N-glycosy-
lated membrane polypeptide(s) during the ﬁrst stages of virus
infection (Ogawa et al., 1998). Initial attempts to identifying IBDV
speciﬁc receptor polypeptides were based on the use of virus overlay
protein binding assays. This approach led to the detection of several
membrane polypeptides speciﬁcally interacting with immobilized
IBDV particles (Nieper and Muller, 1996; Setiyono et al., 2001).
However, their identity and the actual implication on IBDV cell
binding and entry remain uncharacterized. More recently, the use of
IBDV-derived subviral particles (SVP), generated by VP2 recombinant
expression, has led to the identiﬁcation of the chicken heat shock
protein 90 (cHsp90) as amajor component of a putative IBDV receptor
complex including other cellular polypeptides (Lin et al., 2007).Similarly to many other icosahedral viruses (Boulanger, 1999),
some members of the dsRNA Reoviridae family use integrins as
binding receptors and/or essential entry molecules (Graham et al.,
2005, 2006; López and Arias, 2004; Maginnis et al., 2006; Tan et al.,
2001). Integrins form a superfamily of adhesion receptors involved in
a wide variety of matrix–cell and cell–cell interactions. Members of
this superfamily are heterodimers formed by two glycosylated
transmembrane proteins termed α and β, respectively. Both the
structural similarity of the IBDV VP2 P domain to the corresponding
projection domains of reovirus capsid polypeptides (Coulibaly et al.,
2005), and the glycosylated nature of the integrins suggested that
IBDV might also employ an integrin(s) during its cell entry process.
Integrins mediate cell adhesion to extracellular matrix, cell
membrane, and virus capsid polypeptides through the recognition
of short linear ligand sequence motifs. Many integrin-binding motifs
have been extensively characterized (Hynes, 1999; Komoriya et al.,
1991; Plow et al., 2000; Staatz et al., 1991), facilitating the search for
putative integrin-binding motifs within the VP2 sequence. This search
resulted in the identiﬁcation of the Ile-Asp-Ala (IDA) sequence within
the VP2 P domain. That motif matches the XDY triplet (X=G, L, I, E;
Y=V, A) used by the α4β1 integrin in binding to ﬁbronectin (Fn)
(Mould and Humphries, 1991). This ﬁnding prompted us to perform
a series of experiments aimed to characterizing the roles of both the
VP2 IDA motif and the α4β1 integrin on the binding of IBDV to
susceptible cells.
The results described in this report show that, with the virus
strain and cell lines used for the present study, the VP2 IDA motif
plays a critical role in the binding of IBDV-derived SVP and virus
particles to IBDV-susceptible cells, and that a single point mutation
on this motif completely abrogates SVP cell binding and virus
infectivity. Additionally, we demonstrate that transformation with a
recombinant expression plasmid harboring the α4 subunit gene is
sufﬁcient to turn naturally α4-lacking murine BALB/c 3T3 ﬁbroblasts
from resistant to IBDV attachment and infection to permissive for
both phenomena.
Results
Identiﬁcation of a putative integrin-ligand motif within the IBDV capsid
polypeptide
The amino acid sequence of the VP2 polypeptide from the IBDV
Soroa strain was scanned for integrin-binding sequences. This led to
the identiﬁcation of the Ile-Asp-Ala sequence (IDA, residues 234–236)
(Fig. 1B) matching the XDY (X=G, L, I, E; Y=V, A) amino acid triplets
used by theα4β1 integrin in binding to Fn, and in particular to the IDA
motif found in the Fn H1 fragment (Mould and Humphries, 1991). The
identiﬁed VP2 IDA sequence is located within a ﬂexible loop,
connecting the C and D β strands, at the base of the P domain (Fig.1A).
A multiple alignment performed with over 100 VP2 sequences
from antigenic variant, classical virulent, very virulent, as well as
tissue culture-adapted IBDV serotype 1 and serotype 2 isolates,
indicated that the IDA triplet is strictly conserved in all members of
the Avibirnavirus genus. Fig. 1B, showing a multiple alignment of VP2
sequences from representative IBDV strains, summarizes this ﬁnding.
Binding of IBDV-derived SVP to DF-1 cells
In order to assess the feasibility of using IBDV-derived SVP as a
model to analyze the role of the IDA motif on cell attachment, it was
critical to determine whether they were able to bind to IBDV-
susceptible cells. IBDV and SVP were produced, puriﬁed, and analyzed
by EM as previously described (Castón et al., 2001a). DF-1 mono-
layers, grown on coverslips, were incubated for 1 h at 4 °C with a
suspension of either puriﬁed virus or SVP. Thereafter, cells were
processed for CLSM using an anti-VP2 speciﬁc antiserum. As shown in
Fig. 2. IBDV-derived SVP bind to the surface of DF-1 cells and inhibit IBDV infection. (A) DF-1 cultures were incubated for 1 h at 4 °C with a suspension containing either puriﬁed virus
(IBDV) or puriﬁed SVP (SVP). Control cultures (mock) were incubated with DMEM. After incubation, cells were processed for CLSM using speciﬁc anti-VP2 antibodies. The green
signal (Alexa 488) corresponds to VP2. The blue signal (ToPro-3) corresponds nuclear staining. Inlets showa 2.5×magniﬁcation of selected image areas. DF-1 cultures were incubated
with suspensions containing a constant amount of puriﬁed IBDV and increasing SVP concentrations. Cultures were harvested at 16 h p.i., and the corresponding extracts were
analyzed byWestern blotting and qRT-PCR. (B) Western blot analysis. The accumulation of the IBDV-encoded VP3 polypeptide was analyzed using speciﬁc anti-VP3 serum. The total
protein load in the different samples was evaluated using a mouse anti-chicken β-actin antibody. The positions of the β-actin and VP3 polypeptides are indicated by arrows. (C) qRT-
PCR analysis. The amount of IBDV-speciﬁc RNA accumulated in the different cultures was determined by qRTPCR.
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pattern, similar to that observed after incubation of cell monolayers
with puriﬁed virus, thus demonstrating that SVP efﬁciently bind to the
surface of DF-1 cells.
SVP efﬁciently block IBDV infection
Results described above suggested that both IBDV and SVP might
bind to the same cell receptor(s) on the membrane of DF-1 cells. To
test this hypothesis, the ability of SVP to block IBDV infection was
tested. DF-1 monolayers were incubated for 30 min at 37 °C with
suspensions containing a constant amount of puriﬁed IBDV and
increasing SVP concentrations. After incubation, cultures were
maintained at 39 °C during 16 h. Accumulation of the virus-encodedTable 1
Oligonucleotide primers used for VP2 mutagenesis and RT-PCR assays
Sense primer (5′–3′)
Mutation
I234A CTCAGCCAACGCTGATGCCAT
D234A AGCCAACATTGCTGCCATCAC
A236G AACATTGATGGCATCACAAGC
Gene
VP2 (IBDV)a TACCAACCAGGTGGGGTAACA
GAPDH (Gallus gallus)b ATGGTGAAAGTCGGAGTCAAC
GAPDH (Mus musculus)c TGACGTGCCGCCTGGAGAAA
a Accession number AAD30136.
b Accession number AF047874.
c Accession number NM008084.VP3 polypeptide and viral RNA was determined by Western blot and
qRT-PCR, respectively. As shown in Figs. 2B and C, the presence of SVP
at concentrations ≥1 μg/ml causes a major reduction on the
accumulation of both IBDV polypeptides and RNAs. These results
strongly suggest that virions and SVP compete for the same receptor
(s) on the cell surface, and support the use of SVP as a tool to
characterizing IBDV entry mechanism.
Effects of single point mutations of the VP2 IDA sequence on SVP cell
binding
Mutations on the D residue present in the Fn H1 fragment IDAmotif
completely abolish the ability of the fragment to interact with theα4β1
integrin (Mould and Humphries, 1991). Hence, it was important toAnti-sense primer
CACAA GAGGCTTGTGATGGCATCAGCGTTGGCTGA
GTGATGGCAGCAATGTTG
GCTTGTGATGCCATCAATGTT
GCTGGGTTATCTCGTTTGTTGG
G GACAGTGCCCTTGAAGTGTC
AGTGTAGCCCAAGATGCCCTTCAG
363L. Delgui et al. / Virology 386 (2009) 360–372determine the effect of single point mutations of the VP2 IDA triplet on
the ability of SVP to bind DF-1 cells. Accordingly, three mutant VP2
recombinant genes harboring the following single amino acid substitu-
tionswere generated: i) I234A (ADA-SVP); ii) D235A (IAA-SVP); and iii)Fig. 4. A single point mutation on IDA sequence motif abrogates the ability of SVP to
block IBDV infection. DF-1 cultures were incubated with suspensions containing a
constant amount of puriﬁed IBDV and increasing concentrations of IAA-SVP. At 16 h p.i.,
cells were harvested, and the corresponding extracts analyzed byWestern blotting, and
qRTPCR, respectively. (A) Western blot analysis. The accumulation of the IBDV-encoded
VP3 polypeptide was analyzed using speciﬁc anti-VP3 serum. The total protein load in
the different samples was evaluated using a mouse anti-chicken β-actin antibody. The
positions of the β-actin and VP3 polypeptides are indicated by arrows. (B) qRT-PCR
analysis. The amount of IBDV-speciﬁc RNA accumulated in the different cultures was
determined by qRTPCR.A236G (IDG-SVP) (Table 1). All threemutant polypeptides, expressed in
H5 cells using rBVs, gave rise to standard amounts of SVP. SVP resulting
from the expression of mutant VP2 genes were puriﬁed, negatively-
stained, and observed by EM. As shown in Fig. 3A, the mutations
introduced on the VP2 sequence do not cause a microscopically
detectable effect on the morphology or the size of the resulting SVP.
To characterize the effect of the described mutations on SVP cell
binding activity, DF-1monolayers were incubated with suspensions of
puriﬁed SVP. After incubation, cultures were processed for CLSM
analysis using anti-VP2. The results of this analysis, shown in Fig. 3B,
demonstrate that whilst mutant ADA- and IDG-SVP retain to some
extent the ability to attach to DF-1 cells, IAA-SVP are apparently
unable to bind to the cell surface. In order to conﬁrm these results, a
quantitative analysis was performed using images collected from
three independent experiments simultaneously performed with all
SVP under analysis. The results of this analysis (Fig. 3C) conﬁrmed the
initial observations. Reductions of 85 and 59% with respect to control
WT-SVP were observed with ADA- and IDG-SVP, respectively. As
expected, a higher drop on cell binding activity (≥95%) was
documented with IAA-SVP.
These results led us to hypothesize that IAA-SVP might have also
lost the ability to compete IBDV infectivity. To asses this possibility, a
series of SVP/IBDV competition experiments was performed. DF-1 cell
monolayers were incubated for 30 min at 37 °C with suspensionsFig. 3. Characterization of IBDV-derived SVP containing single point mutations on the
IDA sequence motif. (A) Electron microscopy images corresponding to negatively
stainedWT IDA-, mutant ADA-, IAA-, and IDG-SVP, respectively. The scale bar represents
50 nm. (B) Binding of mutant SVP to DF-1 cells. DF-1 cultures were incubated with
suspensions containing WT- ADA-, IAA-, and IDG-SVP, respectively. After incubation,
cells were processed for CLSM using speciﬁc anti-VP2 antibodies. Green (Alexa 488)
corresponds to VP2. Blue signal (ToPro-3) corresponds to nuclear staining. (C)
Quantiﬁcation of the relative intensity of ﬂuorescence signals.
Fig. 5. Three-dimensional reconstructions of WT IDA- and mutant IAA-SVP. (A, B) Surface-shaded representations of the outer surfaces of WT- (A) and IAA-SVP (B) viewed along a
ﬁve-fold axis of icosahedral symmetry, at 9.1 Å resolution. Inlets show representative cryo-micrographs of WT- (left) and IAA-SVP (right). The scale bar represents 200 Å. (C)
Structural homology of WT- and IAA-SVP assessed by the FSC resolution curve between both maps. The resolutions where the correlations drop below 0.5 and 0.3 are indicated. For
the 0.3 threshold, both maps are identical at 9.1 Å (for the 0.5 threshold, the value is 10.5 Å). (D) SVP 50-Å-thick slab of WT- (left) and IDA-SVP (right) three dimensional
reconstructions. The scale bar represents 50 Å.
364 L. Delgui et al. / Virology 386 (2009) 360–372containing a constant amount of puriﬁed IBDV and increasing
concentrations of eitherWT- or IAA-SVP. After incubation, monolayers
were maintained at 39 °C during 16 h. After this period, cultures were
harvested, and the accumulation of the virus-encoded VP3 polypep-
tide and viral RNA determined by Western blot and qRT-PCR,
respectively.
As shown in Figs. 4 and B, IAA-SVP have a much lesser impact on
IBDV infectivity than that observed with WT-SVP (Fig. 2), thus
indicating that, in addition to the reduction on the binding capacity,
the D235A substitution strongly reduces the ability of SVP to block
IBDV infection. The observation that non-binding IAA-SVP retain to
some extent their ability to block IBDV infection was not unexpected.
We have previously shown that SVP and IBDV particles form regularly
shaped aggregates (Castón et al., 2001a). X-ray analysis revealed that
this phenomenon is due to the establishment of extensive contacts
between the VP2 P domains of neighboring particles (Garriga et al.,2006). Hence, it seems likely that, when present at high concentra-
tions, SVP might interact with infectious virus particles, thus
preventing the contact of the latter with speciﬁc cell receptor
molecules, and consequently reducing their infectivity.
The results obtained correlatewith the deﬁnition of FnH1 IDAmotif,
where mutations affecting the central aspartate residue cause the loss
of the Fn H1 adhesive activity (Mould and Humphries, 1991), and
further support the hypothesis that the VP2 IDA sequence is directly
implicated in the binding of SVP and virus particles to DF-1 cells.
Structural characterization of IAA-SVPs
The results described above strongly suggested that the D235A
substitution might be responsible for a drastic alteration on the ability
of the resulting SVP to interact with a cell surface receptor. However,
the available information did not rule out the possibility that this
Table 2
Virus titers obtained by reverse genetics
Virus titers (PFU/ml)
First round Second round Third round
pT7-SA-Rz
+ 1.3±0.5×102 9.0±1.3×104 6.0±1.5×107
pT7-SB-Rz
pT7-SA(D235A)-Rz
+ 0 0 0
pT7-SB-Rz
365L. Delgui et al. / Virology 386 (2009) 360–372mutation might affect either the stability and/or the overall
architecture of the SVP. To gather information about SVP stability,
suspensions containing 100 μg/ml of either WT- or IAA-SVPs were
prepared using DMEM, and collected after a 2 h incubation period at
4 °C, from DF-1 cultures. SVP suspensions were subjected to a sucrose-
gradient-based puriﬁcation process as previously described. Samples
from fractions collected from the corresponding gradients wereFig. 6. The binding of IBDV and SVP to BALB/c 3T3 cells is dependent upon the expression of t
with (A) suspensions of puriﬁed virus or (B) puriﬁed WT- and IAA-SVP, respectively. After i
signal (Alexa 488) corresponds to VP2. The blue signal (ToPro-3) corresponds nuclear stain
represented as percentages with respect to values obtained in cultures of [α4+] Balb/c 3T3subjected to SDS-PAGE and Western blot using anti-VP2 serum. The
results of this analysis did not evidenced signiﬁcant differences on the
stability of wild type and mutant SVPs (data not shown).
In order to explore the effect of the D235A substitution on the
structure of the mutant SVP, three-dimensional density maps of WT-
and IAA-SVP capsids were generated using images from cryomicro-
graphs (Figs. 5A, B, inlets). The ﬁnal SVP density maps were calculated
to a 7.2 Å and 9.3 Å resolution, respectively (Figs. 5A, B). At this
resolution, numerous rod- and sheet-like densities are apparent (Figs.
5A, B, and D), and secondary structural elements were identiﬁed by
docking the closely related 2.6 Å VP2 X-ray map (PDB entry 2GSY)
(Garriga et al., 2006) into both density maps (Supplemental
information, Fig. S1). The molecular architecture of IAA-SVP is
essentially identical to that of previously described WT-SVP (Bottcher
et al., 1997; Castón et al., 2001a; Coulibaly et al., 2005) at ∼9 Å
resolution, as assessed by FSC calculated between them (Fig. 5C).
Altogether, the results of the structural analysis rule out the
possibility that the non-binding phenotype observed with IAA-SVPs
might be due to a conspicuous alteration on SVP architecture.heα4 integrin subunit. (A and B) [α4−] and [α4+] BALB/c 3T3 cultures were incubated
ncubation, cells were processed for CLSM using speciﬁc anti-VP2 antibodies. The green
ing. (C and D) Quantiﬁcation of the relative intensity of ﬂuorescence signals. Data are
cells (C) or in cultures incubated with WT-SVP (D).
Fig. 7. Expression of the α4 integrin subunit is essential for the susceptibility of BALB/c 3T3 cells to IBDV infection. [α4−] and [α4+] BALB/c 3T3 cultures were incubated with
puriﬁed IBDV or with normal medium (−), and maintained at 37 °C. At 24, 48, and 72 h p.i., cells were harvested and the corresponding extracts analyzed by qRTPCR and Western
blot. (A) qRT-PCR analysis. The amount of IBDV-speciﬁc RNA accumulated in the different cultures was determined by qRTPCR. (B) Western blot analysis. The accumulation of the
IBDV-encoded VP3 polypeptidewas analyzed using speciﬁc anti-VP3 serum. The total protein load in the different samples was evaluated using a rabbit anti-mouse β-actin antibody.
The positions of the β-actin and VP3 polypeptides are indicated by arrows. (C) CLSM analysis. [α4−] and [α4+] BALB/c 3T3 cultures were incubated with puriﬁed IBDV, and
maintained at 37 °C. At 24, 48, and72h p.i., cellswere processed for CLSMusing speciﬁc anti-VP3 antibodies. The green signal (Alexa 488) corresponds toVP3. The blue signal (ToPro-3)
corresponds to nuclear staining. (D) Virus titrations. Supernatants corresponding to the different cultureswere used for virus titrations. Virus titers are expressed as PFU/ml. Presented
data corresponds to three independent experiments.
Fig. 8. Inhibition of IBDV infectivity by anti-integrin speciﬁc Abs. [α4+] BALB/c 3T3
cells cultures were pretreated for 1 h at 4 °Cwith Abs speciﬁc to integrin subunits before
infecting with puriﬁed IBDV for 20 h. Results, corresponding to three independent
experiments performed in duplicate, are presented as the percentage of virus infectivity
obtained in cells preincubated in the absence of Abs (−).
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Results described so far demonstrate that the VP2 IDA triplet is
critical for the binding of SVP to the membrane of IBDV-susceptible
DF-1 cells. Hence, it was important to assess the relevance of this
tripeptide on IBDV infectivity. This analysis was carried out using a
reverse genetics approach using plasmids pT7-SA-Rz and B pT7-SB-Rz
containing the cDNA sequences corresponding to IBDV segments A
and B, respectively. A third plasmid, pT7-SA/D235A-Rz, harboring a
mutant version of segment A cDNA containing the D235A substitution
was generated as described above.
QM7 cells were transfected with a mixture of plasmids pT7-SA-
Rz and pT7-SB-Rz, and pT7-SA/D235A-Rz and pT7-SB-Rz, respec-
tively. After transfection, cultures were infected with VT7LacOI. At
72 h p.i., cultures were harvested, and used to assess the presence of
infective IBDV.
The results obtained, presented in Table 2, demonstrate that the
D235A substitution abolishes the production of an infectious IBDV
progeny. Western blot analysis indicated that failure to recovering
infectious IBDV from cells transfected with plasmids pT7-SA/D235A-Rz
and pT7-SB-Rz was not due to problems in the expression of the
polyprotein containing the D235A substitution (data not shown).This ﬁnding, in agreement with the observations described above,
evidences the critical importance of the VP2 D235 residue on IBDV
infectivity.
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murine BALB/c 3T3 cells
The results described above suggested that the α4β1 integrin
might act as a binding receptor for IBDV. Our initial strategy to asses
this possibility was based on the silencing of α4 and/or β1 subunit
gene expression. However, repeated attempts to blocking the
expression of these genes using different RNA oligonucleotide sets
failed (data not shown). Consequently, we decided to explore an
alternative approach based on the use of a previously described BALB/
c 3T3 cell system. Murine BALB/c 3T3 ﬁbroblasts do not naturally
express the α4 subunit, thus their cell membrane lacks the α4β1
integrin (Zeller et al., 1998). Caruso et al. (2003) generated a couple of
BALB/c 3T3-derived cell lines, termed [α4+] and [α4−] BALB/c 3T3,
respectively. The only documented difference between these two cell
lines being the expression of the α4 subunit, and the consequent
presence of the α4β1 heterodimer on the membrane of [α4+] cells.
Before initiating our experiments, the expression of the α4 and β1
integrins at the surface of [α4+] and [α4−] BALB/c 3T3 cells was
analyzed by ﬂow cytometry. The β1 subunit was abundantly
expressed on both [α4+] and [α4−] cells. As expected, the expression
of the α4 subunit was exclusively detected in [α4+] BALB/c 3T3 cells
(Data not shown).
The ability of IBDV particles as well as WT- and IAA-SVP to
bind to [α4+] and [α4−] BALB/c 3T3 cells was analyzed by CLSM.
Cell monolayers were incubated with suspensions containing
puriﬁed virus, WT-, and IAA-SVP, respectively. After incubation,
cells were processed for CLSM analysis using anti-VP2 antiserum.
As shown in Figs. 6A, B, IBDV virions and WT-SVP efﬁciently attach
to [α4+] BALB/c 3T3 cells but do not to [α4−] BALB/c 3T3 cells.
Interestingly, IAA-SVP do not bind neither [α4+] nor [α4−] BALB/
c 3T3 cells (Figs. 6A, B). Quantitative analyses of CLSM images
(Figs. 6C, D) conﬁrmed the information gathered by the direct
microscopic observation.
As described above, IBDV uses the Hsp90 polypeptide as a post-
binding receptor (Lin et al., 2007). It has been recently shown that
depletion of the Hsp90 polypeptide from murine B lymphocytes
results in a major reduction on the surface expression of the α4β1
integrin (Liu and Li, 2008). Accordingly, it seemed feasible that α4β1
expression might enhance Hsp90 surface expression. This might
facilitate the interaction of SVP with Hsp90 instead of with the α4β1
integrin under study. However, as determined by ﬂow cytometry
analyses, both cell lines, [α4+] and [α4−] BALB/c 3T3, exhibit
negligible Hsp90 surface levels (Supplemental data Fig. S2), thus
ruling out such possibility.
The results of this series of experiments show that the attachment
of both IBDV and SVP to BALB/c 3T3 cells is strictly dependent upon
the presence of the α4β1 integrin at the cell membrane.
α4β1 integrin expression is an essential factor for the susceptibility of
BALB/c 3T3 cells to IBDV infection
Results described above demonstrate that theα4β1 heterodimer is
essential for IBDV attachment to BALB/c 3T3 cells. However, at this
point we could not rule out that IBDV binding to α4β1-expressing
cells might be unrelated with the ability of the virus to enter the cells
and initiate a productive infection. To investigate this possibility [α4
+] and [α4−] BALB/c 3T3 monolayers were incubated for 1 h at 37 °C
with puriﬁed IBDV. At 24, 48, and 72 h p.i., cells were harvested and
used for qRT-PCR, CLSM, Western blot, and virus titration analyses.
The results obtained clearly evidenced that incubation of [α4+]
BALB/c 3T3 cells leads to accumulation of IBDV-speciﬁc RNAs (Fig.
7A), and the IBDV VP3 polypeptide (Figs. 7B and C). Additionally, virus
titrations showed that [α4+] BALB/c 3T3 support the production of
an infectious progeny (Fig. 7D). The low IBDV titers obtained were
expected due to the fact that the virus had not been previouslyadapted to growing in this cell line. As expected from previous results,
[α4−] BALB/c 3T3 were completely resistant to IBDV infection as
evidenced by their resistance to accumulate IBDV-speciﬁc RNAs and
polypeptides, and to produce infective virus (Figs. 7A–D).
Taken together, these results demonstrate that the presence of the
α4β1 heterodimer allows the initiation of a productive IBDV
replication cycle, thus demonstrating that the α4β1 integrin acts as
a bona-ﬁde receptor for IBDV in [α4+] BALB/c 3T3 cells.
Inhibition of IBDV infectivity by function-blocking anti-α4 and -β1 mAbs
To further conﬁrm the role of the α4β1 heterodimer on the ability
of transfected [α4+] BALB/c 3T3 cells to support IBDV infection, the
effect of anti-α4β1 function-blocking mAbs was analyzed. [α4+]
BALB/c 3T3 cultures were incubated for 1 h at 4 °C with mAbs
directed against the α4 or the β1 polypeptide, or a combination of
both. As controls for this experiment, cultures were also incubated
with anti-αVβ6 integrin mAb as well as with irrelevant mAbs of the
same isotype to those speciﬁc for α4 and β1 subunits. Cultures were
then incubated for 1 h at 4 °C with 1 PFU/cell of puriﬁed IBDV and
maintained for 20 h at 37 °C. Infectivity was calculated by counting
the number of VP3-positive cells versus the total cell count.
Infectivity reductions of 53±11% and 52±13% were observed in
cells pre-treated with anti-α4 and -β1 mAbs, respectively (Fig. 8).
The combination of the anti-α4 and -β1 mAbs do not further increase
the blocking activity observed with single mAb treatments. As
expected, pretreatments with irrelevant control mAbs do not
signiﬁcantly affect IBDV infectivity.
Reductions on IBDV infectivity, nearing 50%, obtained with the
anti-α4 and -β1 mAbs used in our study are similar to those
previously described with other function-blocking mAbs directed
against integrins involved in the attachment and/or entry of different
naked icosahedral viruses (Coulson et al., 1997; Guerrero et al., 2000;
Hewish et al., 2000; Londrigan et al., 2000). Together with data
described above, these results demonstrate that the α4β1 integrin is
involved in the entry of IBDV into BALB/c 3T3 cells.
Discussion
IBDV SVP are produced as a result of the expression of the mature
form of the VP2 protein (Castón et al., 2001a). This recombinant
polypeptide self-assembles into all-pentamer particles (23 nm in
diameter) formed by 20 VP2 trimers exhibiting an icosahedral T=1
symmetry (Castón et al., 2001a; Saugar et al., 2005). The SVP atomic
structure has been solved by X-ray crystallography (Coulibaly et al.,
2005; Garriga et al., 2006; Lee et al., 2006). SVP VP2 trimers are
identical to the type a trimers that conform the 12 pentamers found
within the IBDV particle (Castón et al., 2001a). The use of IBDV-
derived SVP to studying the IBDV entry process was ﬁrst described by
Lin et al (Lin et al., 2007). In their report, the authors showed that
SVP readily bind the membrane of IBDV-susceptible DF-1 cells, and
are able to efﬁciently block IBDV infection. The results presented here
agree with previously published information (Lin et al., 2007).
Additionally, our work demonstrates that SVP compete, in a dose-
dependent manner, the binding of infectious particles to the cell
membrane, thus indicating that the ability to prevent IBDV infection
is due a direct blockade of virus attachment. Although data presented
here were obtained with DF-1 cells, similar observations were made
with other IBDV-susceptible avian cell lines, i.e. QM7 (quail muscle
cells) and DT40 (bursal chicken lymphocytes), as well as with α4β1-
expressing BALB/c 3T3 murine cells (data not shown), thus showing
that the SVP-induced blockade of IBDV attachment and infectivity is a
general phenomenon. Despite size and structural differences
between IBDV virions and SVP, the results presented here reinforce
the notion that the latter constitute a valuable tool to dissecting the
IBDV entry mechanism.
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A large number of viruses use members of the integrin superfamily
as speciﬁc cell receptors at the attachment or post-attachment level
(Stewart and Nemerow, 2007). The interaction of integrins to their
ligands occurs through the recognition of short linear sequence motifs
on their ligands. The availability of a number of well-characterized
integrin-ligand motifs facilitated our search for putative integrin
ligand motifs on the VP2 primary sequence. As described above, this
search resulted in the identiﬁcation of the IDA motif, matching the
previously described consensus sequence of amino acid triplets
employed by Fn to bind the α4β1 integrin (Mould and Humphries,
1991). Additionally, the detected VP2 IDA triplet is placed within a
ﬂexible loop connecting two long β sheets, thus fulﬁlling an important
structural feature common to integrin ligands: the location of the
critical acidic (D or E) residue within a ﬂexible loop (Michishita et al.,
1993; Ruoslahti, 1996).
The strict conservation of VP2 IDA triplet across the Avibirnavirus
genus suggested that this tripeptide might play a critical role on virus
replication. Furthermore, the putative speciﬁcity of the IDA sequence
for the α4β1 hetrodimer, a highly abundant integrin in immature
lymphocytes (Rose et al., 2002) themain IBDV cell target (Becht,1980;
Kibenge et al., 1988), led to the hypothesis that IBDV might use this
integrin during its entry mechanism. Although RT-PCR analyses
showed the presence of RNA transcripts corresponding to both α4
and β1 integrin subunit genes in DF-1 cells (data not shown), the lack
of commercially available antibodies speciﬁcally recognizing the avian
α4 subunit precluded the possibility of directly assessing the presence
of the α4β1 heterodimer on the membrane of the avian cells. The
generation of a set of antibodies directed to the extracellular moiety of
the α4 subunit, currently ongoing in our laboratory, will provide an
essential tool for the future characterization of its expression in
chicken cells, and to further analyze its role on IBDV infection both in
vivo and in vitro.
Results gathered with SVP harboring single point mutations on
the IDA triplet demonstrate that this sequence, and in particular
the central aspartate residue, is essential for: i) SVP binding to the
cell membrane; and ii) the ability of SVP to hinder the attachment
of IBDV virions to the cell membrane, and block virus infection.
These results strongly resemble those obtained with soluble
peptides used to characterize the speciﬁcity of α4β1-binding
sequences within the Fn H1 (Mould and Humphries, 1991). The
structural analysis performed on mutant IAA-SVP indicates that the
documented non-binding phenotype of mutant IAA-SVP is a direct
consequence of the functional inactivation of the α4β1 binding
motif. Furthermore, the results of the reverse genetic experiments
demonstrate that the D235A mutation completely arrests virus
viability. It seems plausible that the lethality of the D235A
mutation might be a direct consequence of the inability of the
VP2 D235A-bearing IBDV particles to attach to the membrane of
target cells.
Noteworthy, a comparison of VP2 primary sequences from
representative members of the different birnavirus genus (Avibirna-
virus, Acquabirnavirus, and Entomobirnavirus) showed a strict con-
servation of the IDA D residue across the family (Supplemental
information Fig. S3), thus suggesting that it might also play a critical
role in the life cycle of other birnaviruses.
The role of α4β1 integrin on IBDV cell binding and replication
Murine BALB/c 3T3 cells do not naturally express the α4 subunit,
thus being devoid of the α4β1 integrin (Zeller et al., 1998). Two
stably transfected BALB/c 3T3-derived cell lines, exclusively differ-
ing on the expression of the α4 subunit, were previously generated
by Caruso et al (Caruso et al., 2003) as a convenient tool analyzingthe role of the α4β1 integrin during the entry process of murine
polyomavirus. We borrowed these cell lines to determine whether
the expression of the α4β1 integrin might be related with the
ability of IBDV to bind to the cell membrane. The analysis of the
results obtained with this cell system clearly demonstrate that the
presence of the α4β1 heterodimer is a critical factor for the binding
of both IBDV and IBDV-derived SVP to the cell surface. The
speciﬁcity of these results was further conﬁrmed by the non-
binding phenotype exhibited by mutant IAA-SVP lacking an active
α4β1-binding motif.
According to results obtained with BALB/c 3T3 cells, in addition to
facilitating the binding to the cell membrane, the α4β1 heterodimer
acts as a key factor for IBDV infection. This shows that, in this cell
system, the IBDV–α4β1 interaction is essential in triggering the access
of the virus to a cellular compartment suitable for virus replication,
and thus allowing the production of an infective virus progeny. Hence,
demonstrating that the murine α4β1 integrin acts as bona-ﬁde
binding receptor for IBDV.
IBDV isolates have been successfully adapted to replicate in
established mammalian cells, i.e. Vero and BSC-1 cells (Lombardo et
al., 2000; Yip et al., 2007). Tissue culture-adapted IBDV strains are
able to bind to a speciﬁc cell receptor(s), enter the cell, and carry
out a productive replication process, thus giving rise to an infective
virus progeny. It was previously thought that tissue culture
adaptation was strictly related to the ability of the adapted viruses
to bind to a receptor(s) different from that present in natural IBDV
cell targets. However, it has been recently shown that VP2
polypeptides from the non-adapted very virulent HK46 isolate and
the tissue culture-adapted D78 IBDV strain share the same binding
receptor on the membrane of Vero cells (Yip et al., 2007). This
ﬁnding shows that the restriction to tissue culture growth exhibited
by, at least, some non-adapted viruses takes place at a post-binding
step (Lombardo et al., 2000; Yip et al., 2007). In view of the results
presented here, it seems feasible that the α4β1 integrin might also
act as a binding receptor in bursal lymphoid cells. However, further
studies will be required to determine whether this is the case.
Although speciﬁc information regarding the IBDV entry mechan-
ism is scarce, available data suggests that IBDV enters susceptible cells
using a receptor-mediated endocytic pathway (Galloux et al., 2007;
Lin et al., 2007). The interaction between IBDV particles and the α4β1
integrin might afford virus–cell binding. This step could be followed
by the interaction with the cHsp90α protein and, probably, other
cellular polypeptides required for successful virus entry.
Materials and methods
Viruses, cells, and antibodies
The IBDV Soroa strain, a virulent serotype 1 virus, was propagated
and titrated in QM7 quail muscle cells (ATCC, CRL-1962) as previously
described (Lombardo et al., 1999). BALB/c 3T3-derived cell lines [α4
+] and [α4−] BALB/c 3T3, kindly provided by Dr. Paolo Amati, were
grown in DMEM containing 10% FCS and supplemented with
puromycin at 1.3 μg/ml. [α4+] BALB/c 3T3 cells are stably transfected
with pRK5-α4, a plasmid expression vector carrying the cDNA of the
murine α4 integrin subunit. [α4−] BALB/c 3T3 cells are stably
transfected with the empty version of the pRK5 plasmid (Caruso et al.,
2003). Construction of recombinant baculoviruses (rBVs) FB/VP2-
452, FB/VP2-452(I234A), FB/VP2-452(D235A) and FB/VP2-452
(A236G) is described below. rBV stocks were grown and titrated in
S. frugiperda H5 insect cells (Invitrogen) as described before (Maraver
et al., 2003). H5 insect cells were infected with the appropriate rBVs,
and used to produce and purify SVP using sucrose gradients as
described previously (Castón et al., 2001b). The recombinant vaccinia
virus (rVV) VT7LacOI was grown and titrated as previously described
(Ward et al., 1995). H5 cells were grown at 28 °C in TC100 medium
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(ATCC, CRL-12203) were grown at 37 °C and 39 °C, respectively, in
Dulbecco's modiﬁed Eagle's medium (DMEM) containing 10% inacti-
vated fetal calf serum (FCS). [α4+] and [α4−] BALB/c 3T3 cells were
grown at 37 °C in DMEM containing 10% FCS and supplemented with
1.3 μg/ml of puromycin.
Western blot and confocal laser scanning microscopy (CLSM)
analyses were carried out using anti-VP2 and -VP3 speciﬁc sera as
previously described (Fernandez-Arias et al., 1998). The monoclonal
antibody (mAb) mAbC3, speciﬁc for the 14K rVV structural polypep-
tide (Rodriguez et al., 1985), was used to detect the presence of
contaminant rVV in reverse genetic assays.
Function-blocking antibodies directed to mouse integrin subunits
α4 (CD49d, clone R1-2) and its isotype control mAb (A95-1) were
purchased from BD PharMingen. mAbs directed to mouse integrin
subunit β1 (CD29, clone HMβ1-1) and its control isotype mAb
(eBio299Arm) were purchased from eBioscience. mAbs to αVβ6
integrin (mAb 2077Z) was purchased from Chemicon. The mAb anti-
β-actin (AC-15), purchased from Sigma, was used to control the total
protein content of cell extracts under study.
IBDV titration
Monolayers of DF-1 cells grown in 6-well tissue culture plates were
infected with serial dilutions of infected cell supernatants. Following
virus adsorption for 60 min at 37 °C, the inoculums were removed.
Infected cells were washed twice with DMEM without serum and
incubated with fresh DMEM containing 2% of FCS at 39 °C in a 5% CO2
atmosphere. At 72 h p.i., cells were ﬁxed in acetone-methanol (1:1),
washed, and incubated for 60minwith anti-VP3 antibodies, followed by
incubation with horseradish-peroxidase-conjugated polyclonal goat
anti-rabbit antibody. Thereafter, plates were washed with phosphate
buffer saline (PBS), and horseradish-peroxidase-conjugated polyclonal
goat anti-rabbit antibody (GE Healthcare) added. The mixture was
incubated for 45min at 20 °C. After washingwith PBS, antibody-labeled
cells were developed using 3, 3′-diaminobenzidine (Sigma) substrate
solution, foci of stained cells were counted, and virus titers calculated.
Reverse genetic analysis
DNA fragments containing cDNA versions corresponding to the
complete positive strand RNAs corresponding to the IBDV Soroa strain
segments A and B, fused to the T7 bacteriophage promoter (in 5′
position with respect of the cDNA) and a cDNA corresponding to the
hepatitis delta virus ribozyme (in 3′ position with respect of the
cDNA) sequences were generated by in vitro gene synthesis (Gene-
script Co.), and inserted into the multiple cloning site of the pUC57
cloning plasmid (GenBank/EMBL accession number Y14837). These
plasmids were named pT7-SA-Rz, containing the cDNA corresponding
to segment A, and pT7-SB-Rz, containing the cDNA corresponding to
segment B, respectively.
Plasmid pT7-SA-Rz was used as the template for the introduction
of selected point mutations, using a PCR-based protocol, on the VP2
coding region. The core-coding region of VP2 was ampliﬁed using
primers (Table 1) containing the desired nucleotide changes to
generate the D235A mutation. Primary PCR products containing the
engineered mutations were assembled by PCR ampliﬁcation with the
ﬂanking primers 5′-TCACCGTCCTCAGCTTAC and 5′-TCAGGATTTGG-
GATCAGC. The resulting DNA fragments were puriﬁed, digested with
BamHI and NdeI, and ligated to pT7-SA-Rz previously digested with
the same enzymes. The resulting plasmid, pT7-SA(D235A)-Rz, was
ampliﬁed, and analyzed by nucleotide sequencing to determine the
correctness of its sequence.
QM7 cells seeded in 60-mm dishes (1.5×106 cells/dish) were
transfected with a combination of either pT7-SA-Rz and pT7-SB-Rz or
pT7-SA(D235A)-Rz and pT7-SB-Rz, respectively. Transfections werecarried out with 2.5 μg of each plasmid using lipofectamine (Gibco
BRL). At 6 h after transfection, cultures were infected with 1 PFU/cell
of VT7LacOI, an rVV inducibly expressing the T7 RNA polymerase
(Ward et al., 1995). After infection, cultures were maintained at 37 °C
in DMEM containing 10% FCS supplemented with the inducer
isopropyl β-D-thiogalactoside (IPTG) (1 mM ﬁnal concentration). At
72 h p.i., cultures were harvested, and subjected to three freeze–
thawing cycles. After removing cell debris by low speed centrifugation
(10,000 ×g for 5min at 4 °C), supernatants were recovered and passed
through 0.1 μm ﬁlters (MillexVV, Millipore) to eliminate contaminant
rVV particles, and used to infect fresh QM7 cell monolayers. Infections
were performed in quadruplicate with undiluted and 10−1 to 10−5
serial dilutions of the initial stocks. Two sets of infected cells were
used to determine the IBDV titer at 72 h p.i. Another set was harvested
at 72 h p.i., and the corresponding extracts used to detect the presence
of IBDV VP1 and VP2 polypeptides by Western blot using speciﬁc
antibodies. The absence of contaminant infecting rVV particles was
also monitored by Western blot, using the mAbC3. The fourth cell set
was also harvested at 72 h p.i., and used to collect cells originally
infected with the undiluted stocks. These samples were subjected to
three freeze–thawing cycles, and used to repeat the procedure
described above. The process was repeated once more, thus allowing
the analysis of the initial virus stock and two subsequent virus
ampliﬁcation rounds.
Construction of rBVs
A DNA fragment corresponding to the region encoding the 452 N-
terminal residues of the IBDV polyprotein was generated by PCR
synthesis using pFastBac/POLY (Martinez-Torrecuadrada et al., 2000).
PCR reactions were carried out with Vent DNA polymerase (New
England Biolabs) using primers 5′-GCGCAGATCTATGACAAACCTGTCA-
GATCAAACCC and 5′-GCGCAAGCTTACCTTATGGCCCGGATTATGTCTTT-
GAAGC. The resulting DNA fragment was puriﬁed, digested with BglII
and HindIII and cloned into the pFastBac1 plasmid (Invitrogen)
previously digested with BglII and HindIII. The resulting plasmid
vector, pFB/VP2-452, was used as the template for the introduction of
selected point mutations using a PCR-based protocol. The core-coding
region of VP2-452 was ampliﬁed using primers containing the desired
changes (Table 1). Primary PCR products containing the engineered
mutations were assembled by ampliﬁcationwith the ﬂanking primers
5′-TCACCGTCCTCAGCTTAC and 5′-TCAGGATTTGGGATCAGC. The
resulting DNA fragments were puriﬁed, digested with BamHI and
NdeI, and ligated to pFB/VP2-452 previously treated with the same
enzymes, giving rise to plasmids pFB/VP2-452(I234A), pFB/VP2-452
(D235A), and pFB/VP2-452(A236G).
Protein sequence analysis
Searches for integrin binding consensus sequenceswithin the IBDV
VP2 protein, and sequence alignments were carried out using the
CLUSTAL W multiple-sequence alignment software (Larkin et al.,
2007). Birnavirus VP2 sequences were retrieved fromUniProt (http://
www.pir.uniprot.org/).
SVP blockade of virus infectivity
DF-1 and transfected BALB/c 3T3 cells were grown into 24-well
plates with DMEM supplemented with 5% FCS for 16 h. Thereafter, the
mediumwas removed, and cells incubated with suspensions contain-
ing a constant amount of 5×105 PFU/ml of puriﬁed IBDV and
increasing SVP concentrations (0.01–100 μg/ml). SVP/virus suspen-
sions were prepared in DMEM. Monolayers were covered with 500 μl
of the corresponding SVP/virus suspension, and maintained at 37 °C
for 30 min. Thereafter, cultures were washed, supplemented with
fresh medium, and maintained for 16 h at 39 °C (DF-1 cells) or 32 h at
370 L. Delgui et al. / Virology 386 (2009) 360–37237 °C (transfected BALB/c 3T3 cells). Finally, cultures were harvested
and divided into two aliquots used to determine the accumulation of
both virus-encoded proteins and viral RNA, respectively.
Western blot analysis
Cell extracts were added to Laemmli's sample buffer to a 1× ﬁnal
concentration, and heated (100°C, 2 min). Electrophoreses were
performed in 11% polyacrilamide gels, followed by electroblotting
onto polyvinylidene diﬂuoride membranes. Membranes were cut into
two halves. The lower half was used to evaluate the accumulation of
the IBDV-encoded VP3 polypeptide, and the upper one to assess the
total protein content usingmouse anti-human or rabbit anti-mouse β-
actin antibodies. For this, membranes were incubated with the
appropriate Abs, and immunoreactive bands detected by the
enhanced chemiluminescence reaction (GE Healthcare).
Conventional electron microscopy analysis
2–5 μl aliquots of SVP-containing samples were placed on top of
copper grids covered with collodion and carbon that had previously
been made hydrophilic by glow discharge. Grids were then incubated
at 20 °C for 2 min. Adsorbed particles were negatively stained for 30 s
with a 2% solution of uranyl acetate. Micrographs were recorded with
a JEOL 1200 EXII electron microscope operating al 100 kV at a nominal
magniﬁcation of 40,000×.
Cryo-electron microscopy (cryo-EM)
SVP suspensions (5 μl drops) were applied to one side of a holey
carbon ﬁlm, blotted, and plunged into a liquid ethane bath following
standard procedures (Castón et al., 2001b; Saugar et al., 2005).
Micrographs were recorded under minimal exposure conditions.
Imaged specimens received exposures of 6–10 e−/nm2 at a nominal
magniﬁcation of 50,000× on a Tecnai G2 electron microscope
operating at 200 kV and equipped with a ﬁeld emission gun.
SVP image analysis
General image processing operations were performed using Bsoft
(http://www.niams.nih.gov/rcn/labbran/lsbr/software/bsoft/),
Xmipp (http://xmipp.cnb.csic.es/), and Spider (http://www.wads-
worth.org/spider_doc/spider/docs/) programs. For the selected
micrographs analyzed, defocus values were determined with the
Bshow program (http://www.niams.nih.gov/rcn/labbranch/lsbr/
software/bsoft/bshow/bshow.html), ranged from 0.6 to 3 μm (ﬁrst
zeros of the contrast transfer function [ctf] at spacing of 11 to 28 Å). A
Zeiss PhotoScan TD scanner was used to digitalize suitable micro-
graphs at 7 μm/pixel (1.4 Å at the specimen), and micrographs were
binned to give 14 or 21 μm/pixel during the initial reﬁnements. The
X3d program (Conway et al., 1993) was used to manually extract
particle images, including 26,386 for wild type IDA (WT-SVP) and
19,433 for mutant IAA-SVP. Initial estimates of the origin and
orientation angles were determined for a base set of particles, using
polar Fourier transform procedures (Baker and Cheng, 1996), taking
previous maps, appropriately scaled at a 28-Å resolution, as a starting
model (Saugar et al., 2005). A new density map was calculated and
used for all subsequent orientation and origin reﬁnements. Phases
were ctf-corrected by ﬂipping them in the required lobes of the ctf
with Bsoft bctf routine. Enhancement of the high-resolution Fourier
amplitudes was carried out with the Spider program as previously
described (40). Three-dimensional density (3D)mapswere calculated
using Fourier–Bessel methods (Crowther, 1971). The ﬁnal reconstruc-
tions combined 23,754 and 17,505 images for WT- and IAA-SVP,
respectively. The resolution was assessed by FSC calculated between
independent half-data-set maps, applying a correlation limit of 0.5 (or0.3). The resolutions calculated for WT- and IAA-SVP were of 7.8 Å (or
7.2 Å) and 10.5 Å (or 9.3 Å), respectively. The structural identity of
both density maps was assessed by FSC calculated between them.
Density maps and atomic models were visualized with UCSF Chimera
software (http://www.cgl.ucsf.edu/chimera/).
RNA isolation and cDNA synthesis
Total RNA was extracted from frozen cells (1×107) using Trizol
(Invitrogen) following the manufacture's recommendations. DNase
digestion of contaminating DNA in the RNA samples was carried out
with the RNase-Free DNase Set (Qiagen). Final RNA puriﬁcation was
performed using the RNeasy Mini Kit (Qiagen) according to standard
protocols. Total RNA (1 μg) was reverse transcribed in a reaction mixture
of 20 μl containing 1× PCR Buffer II (Applied Biosystem), 5 mM MgCl2,
1 mM dNTP, 20 U RNase inhibitor, 50 U MuLV reverse transcriptase
(Applied Biosystems), 5 μM random primers (Gibco) and DEPC treated
dH20.
Real-time quantitative RTPCR (qRTPCR) assays
Transcript levels were determined by qRTPCR using a 7300 Real-
Time PCR System (Applied Biosystems) and SYBR Green dye (Applied
Biosystems). Reactions were performed in a ﬁnal volume of 20 μl
containing 10 μl of 2× Power SYBR Green PCR Master Mix (including
AmpliTaq Gold DNA Polymerase-LD, dNTPs and SYBR Green dye),
250 nM forward and reverse speciﬁc primers (Table 1) and a 1:10
dilution of cDNA. After enzyme activation at 95 °C for 10 min,
ampliﬁcations were carried out using a two-step PCR procedure with
40 cycles of 15 s at 95 °C for denaturation and 1 min at 60 °C for
annealing/extension. Gene speciﬁc primers were designed using the
Oligo Explorer 1.2 software (Gene Link) based on sequences informa-
tion deposited at the National Center of Biotechnology Information.
Primer sequences used in the qRTPCR analyses are described in Table 1.
Non-template controls were included for each primer pair, and
each PCR reaction was completed in triplicate. Data were analyzed
using the 7300 SDS software 1.3 (Applied Biosystems). Dissociation
curves for each amplicon were then analyzed to verify the speciﬁcity
of each ampliﬁcation reaction; the dissociation curve was obtained by
heating the amplicon from 60 °C to 95 °C. For IBDV-SVP competition
experiments speciﬁc RNA contents were calculated using the standard
curve method from triplicate data obtained with the Gallus gallus
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene, as internal
control, and control cultures, infected with IBDV in the absence of SVP,
as reference control samples. For experiments carried out in [α4+]
and [α4−] transfected BALB/c 3T3 cells, speciﬁc RNA contents were
calculated using data obtained with the Mus musculus GAPDH gene, as
internal control, and control uninfected cultures. Results are means of
triplicate data of one representative experiment, and are represented
as the percentage with respect to the reference sample representing a
100% infection value.
Confocal laser scanning microscopy (CLSM) analysis
For binding experiments, puriﬁed IBDV or SVP were used. DF-1 or
[α4+] and [α4−] transfected BALB/c 3T3 cells seeded onto glass
coverslips were incubated with suspensions containing either SVP
(50 μg/ml) or IBDV virions (10 PFU/cell) at 4 °C for 30 min.
Afterwards, cells were methanol-ﬁxed, incubated with rabbit anti-
VP2 speciﬁc serum, followed by incubation with goat anti-rabbit Ig
coupled to Alexa 488 (green). Cell nuclei were stained with ToPro-3.
Fluorescent signals detected by CLSM were visualized by epiﬂuores-
cence using a Zeiss Axiovert 200 microscope equipped with a Bio-Rad
Radiance 2100 confocal system. Images were captured using the Laser
Sharp software package (Bio-Rad). Relative quantiﬁcation of ﬂuores-
cence was performed using LaserPix 4.0 software (ImagePro Plus.
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size in each single confocal section were analyzed to obtain the
relative ﬂuorescence units. Images from three different experiments
were used and media and standard deviation values were calculated.
Treatment of cells with function-blocking anti-integrin MAbs
[α+]-BALB/c 3T3 cellswere grown in 24-well plates, washed twice
with DMEM and incubated at 4 °C for 1 h with or without function-
blocking anti-integrin subunit mAbs (10 μg/ml) diluted in DMEM, and
then infected with IBDV (1 PFU/cell) at 4 °C for 1 h. Cells were washed
and maintained for 20 h at 37 °C in DMEM supplemented with 10%
serum. At this point, cells were ﬁxed and processed for CLSM analysis
using anti-VP3 serum as described above. The percentage of infected
cells was determined by counting the number of infected cells with
respect to the total nuclei number on randomly selected ﬁelds. A
minimum of 5,000 nuclei was counted for each mAb treatment.
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